BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6167253)

  • 1. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
    Willenborg DO; Higgins TJ
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
    Englert D; Hempel K
    Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis.
    Willenborg DO; Sjollema P; Danta G
    J Neuroimmunol; 1986 Apr; 11(2):93-103. PubMed ID: 2419359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
    Waxman FJ; Taguiam JM; Whitacre CC
    Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
    Weber F; Hempel K
    Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
    Strejan GH; Percy DH; St Louis J
    Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by prostaglandin synthesis inhibition.
    Weber F; Hempel K
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):242-5. PubMed ID: 2474512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
    Killen JA; Swanborg RH
    J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
    Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
    Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity in multiple slcerosis: do we have an experimental model?
    Kies MW
    Adv Exp Med Biol; 1978; 100():277-88. PubMed ID: 80941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
    Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
    Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.